Literature DB >> 23804521

Promoter hypermethylation of CDKN2A, MGMT, MLH1, and DAPK genes in laryngeal squamous cell carcinoma and their associations with clinical profiles of the patients.

Stefano Pierini1, Stanislav H Jordanov, Atanaska V Mitkova, Ivan J Chalakov, Mincho B Melnicharov, Kuncho V Kunev, Vanio I Mitev, Radka P Kaneva, Teodora E Goranova.   

Abstract

BACKGROUND: Laryngeal squamous cell carcinoma (laryngeal SCC) is a frequently occurring cancer of the head and neck area. Epigenetic changes of tumor-related genes contribute to its genesis and progression.
METHODS: We assessed promoter methylation status of the selected genes (CDKN2A, MGMT, MLH1, and DAPK) using methylation-sensitive high resolution melting (MS-HRM) in 100 patients with laryngeal SCC and studied the correlations with clinical characteristics.
RESULTS: The prevalence of promoter methylation in MGMT, CDKN2A, MLH1, and DAPK was 59 of 97 (60.8%), 46 of 97 (47.4%), 45 of 97 (46.4%), and 41 of 97 patients (42.3%), respectively. Significantly increased methylation of CDKN2A was observed in heavy smokers. Epigenetic inactivation of CDKN2A and MLH1 were found to be associated with lymph node involvement. An inverse correlation was present between MLH1 methylation and alcohol consumption.
CONCLUSION: Our results strongly suggest that deregulation of p16-associated, and MLH1-associated pathways, because of promoter hypermethylation, is associated with increased cancer cell migration, tumor invasiveness, and, thus, aggressive phenotype.
Copyright © 2013 Wiley Periodicals, Inc.

Entities:  

Keywords:  CDKN2A; MLH1; laryngeal carcinoma; lymph node metastases; promoter hypermethylation

Mesh:

Substances:

Year:  2013        PMID: 23804521     DOI: 10.1002/hed.23413

Source DB:  PubMed          Journal:  Head Neck        ISSN: 1043-3074            Impact factor:   3.147


  19 in total

1.  Mutational Status of CDKN2A and TP53 Genes in Laryngeal Squamous Cell Carcinoma.

Authors:  Teodora A Todorova; Stanislav H Jordanov; Gergana S Stancheva; Ivan J Chalakov; Mincho B Melnicharov; Kuncho V Kunev; Vanio I Mitev; Radka P Kaneva; Teodora E Goranova
Journal:  Pathol Oncol Res       Date:  2014-08-23       Impact factor: 3.201

2.  Aberrant methylation of mutL homolog 1 is associated with increased risk of non-small cell lung cancer.

Authors:  Haochang Hu; Xiaoying Chen; Cong Zhou; Bin Li; Yong Yang; Xiuru Ying; Yiyi Mao; Yihan Zhang; Jie Zhong; Jie Dai; Hang Yu; Boyi Wu; Xiaodong Li; Tiangong Wang; Shiwei Duan
Journal:  J Clin Lab Anal       Date:  2017-12-05       Impact factor: 2.352

Review 3.  Trial watch: DNA-based vaccines for oncological indications.

Authors:  Stefano Pierini; Renzo Perales-Linares; Mireia Uribe-Herranz; Jonathan G Pol; Laurence Zitvogel; Guido Kroemer; Andrea Facciabene; Lorenzo Galluzzi
Journal:  Oncoimmunology       Date:  2017-11-20       Impact factor: 8.110

4.  Alterations of p14 ARF , p15 INK4b , and p16 INK4a Genes in Primary Laryngeal Squamous Cell Carcinoma.

Authors:  Fernando López; Teresa Sampedro; José L Llorente; Mario Hermsen; César Álvarez-Marcos
Journal:  Pathol Oncol Res       Date:  2016-07-04       Impact factor: 3.201

5.  Promoter Hypermethylation Profiling Identifies Subtypes of Head and Neck Cancer with Distinct Viral, Environmental, Genetic and Survival Characteristics.

Authors:  Javed Hussain Choudhury; Sankar Kumar Ghosh
Journal:  PLoS One       Date:  2015-06-22       Impact factor: 3.240

Review 6.  The clinical value of aberrant epigenetic changes of DNA damage repair genes in human cancer.

Authors:  Dan Gao; James G Herman; Mingzhou Guo
Journal:  Oncotarget       Date:  2016-06-14

Review 7.  Predictive value of epigenetic alterations in head and neck squamous cell carcinoma.

Authors:  Jennifer Koffler; Sarika Sharma; Jochen Hess
Journal:  Mol Cell Oncol       Date:  2014-10-29

Review 8.  Early detection and personalized treatment in oral cancer: the impact of omics approaches.

Authors:  Ilda Patrícia Ribeiro; Leonor Barroso; Francisco Marques; Joana Barbosa Melo; Isabel Marques Carreira
Journal:  Mol Cytogenet       Date:  2016-11-23       Impact factor: 2.009

9.  RAB25 expression is epigenetically downregulated in oral and oropharyngeal squamous cell carcinoma with lymph node metastasis.

Authors:  M J A M Clausen; L J Melchers; M F Mastik; L Slagter-Menkema; H J M Groen; B F A M van der Laan; W van Criekinge; T de Meyer; S Denil; B van der Vegt; G B A Wisman; J L N Roodenburg; E Schuuring
Journal:  Epigenetics       Date:  2016-07-05       Impact factor: 4.528

10.  Association of MGMT promoter methylation with tumorigenesis features in patients with ovarian cancer: A systematic meta-analysis.

Authors:  Baoli Qiao; Zhenyu Zhang; Yanfang Li
Journal:  Mol Genet Genomic Med       Date:  2017-11-30       Impact factor: 2.183

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.